ANTI-SIRP-ALPHA ANTIBODIES

ANTI-SIGLEC-9 ANTIBODY MOLECULES

Sequence-Based High Throughput Method Generating Camelids Antibodies to Cover Broad Epitopes with High-Resolution

Anti-plasma kallikrein antibodies

ANTI-CD3 ANTIBODIES AND METHODS OF USE

NANO-ANTIBODY TARGETING CAIX ANTIGEN AND APPLICATION THEREOF

Antibodies specific for CD70 and their uses

ANTIBODIES SPECIFICALLY RECOGNIZING GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR ALPHA AND USES THEREOF

Compositions and methods for treatment of thyroid eye disease

PD-L1 BINDING MOLECULE

HIGH AFFINITY ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE

Anti-CSP antibodies

AN ANTIGEN-BINDING MOLECULE, A PHARMACEUTICAL COMPOSITION, AND A METHOD

BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV

INSERTABLE VARIABLE FRAGMENTS OF ANTIBODIES AND MODIFIED A1-A2 DOMAINS OF NKG2D LIGANDS

MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

Muscle targeting complexes and uses thereof for treating dystrophinopathies

MULTISPECIFIC ANTIBODY

Antibodies binding to HLA-A2/WT1

Tri-specific binding molecules

Antibodies that bind to OX40 and their uses

Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR)

Anti-TrkB monoclonal antibodies and methods of use

ANTIBODIES SPECIFIC TO GLYCOSYLATED CTLA-4 AND METHODS OF USE THEREOF

Bispecific PD-1 and TIGIT binding proteins and uses thereof

COMPOSITIONS AND METHODS FOR MAKING AND USING MULTISPECIFIC ANTIBODIES

PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF

Connexin 43 antibodies and use thereof

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

Anti-ApoE antibodies

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Heterodimeric antibodies that bind CD3 and CD38

Anti-CCR8 antibodies and uses thereof

MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES

NOVEL ANTI-CD3 ANTIBODIES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

THERAPEUTIC USES OF ANTI-TCR DELTA VARIABLE 1 ANTIBODIES

CONDITIONALLY ACTIVE POLYPEPTIDES

NOVEL ANTI-CD47 ANTIBODIES AND USES THEREOF

Cancer Neoepitopes

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

Immunotherapy Targeting Tumor Neoantigenic Peptides

SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS

ANTI-SIGLEC-9 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFLAMMATORY PHENOTYPES AND USES THEREOF

ANTI-CLL1 ANTIBODY AND USE THEREOF

ANTI-PD-L1 ANTIBODY AND PHARMACEUTICAL USE THEREOF

FC VARIANTS WITH REDUCED EFFECTOR FUNCTION

Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof

RAGE ANTIBODIES, FRAGMENTS AND USES THEREOF

ANTIBODIES BINDING TIGIT AND USES THEREOF

ANTI-HUMAN IL6 MONOCLONAL ANTIBODIES, PREPARATION METHOD THEREFOR AND USE THEREOF

PLASMODIUM ANTIBODIES

TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF

MULTISPECIFIC ANTAGONISTS

ANTIBODIES FOR CHELATED RADIONUCLIDES

PD-L1 ANTIBODIES BINDING CANINE PD-L1

HIGH AFFINITY ANTIBODIES TO CD39 AND USES THEREOF

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

Anti-NKG2A antibodies and compositions

Agonists of TREM2

NOVEL ANTI-SEMA3A ANTIBODIES AND USES THEREOF

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

ANTI-IL-27 ANTIBODIES AND USES THEREOF

ANTI-ANGIOPOIETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE

HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3

IgE Antibody with FcRn binding

Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases

MAGE-A4 peptide-MHC antigen binding proteins

METHODS FOR TREATMENT OF B CELL PROLIFERATIVE DISORDERS WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

ENGINEERED PH-DEPENDENT ANTI-CD3 ANTIBODIES, AND METHODS FOR THEIR GENERATION AND USE

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AND METHODS OF USE

Binding molecules specific for FcγRIIA and uses thereof

Anti-MS4A6A antibodies and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Anti-GDF15 antibodies, compositions and methods of use

SERUM ALBUMIN BINDERS

Anti-C7 Antibody Or Antibody Fragment

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Anti-c-Met antibody drug conjugates

MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY

MULTISPECIFIC FGF21 RECEPTOR AGONISTS AND THEIR USES

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

ANTIBODIES AGAINST THE POLIOVIRUS RECEPTOR (PVR) AND USES THEREOF

Anti-CD39 Antibody Compositions and Methods

ANTI-TNFR2 ANTIBODIES AND METHODS OF USE

Anti-CD123 antibodies and conjugates and derivatives thereof

Human antibodies binding to ROR2

MULTIMERIC ANTIBODIES WITH ENHANCED SELECTIVITY FOR CELLS WITH HIGH TARGET DENSITY

ANTIBODIES AND METHODS OF USE

CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER

Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

COMPOUNDS AND METHODS TARGETING EPIREGULIN

Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof

Factor H potentiating antibodies and uses thereof

ANTIBODIES RECOGNIZING TAU

SARS-COV-2 SPIKE PROTEIN ANTIBODIES

Therapeutic Biologic For Treatment Of Hepatocellular Carcinoma

VECTORS FOR USE IN AN INDUCIBLE COEXPRESSION SYSTEM

CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF

CD123 binding proteins and related compositions and methods

MULTISPECIFIC ANTIBODIES

VHH immunoglobulin chain variable domain that binds to IL-7R and methods of use thereof for treating autoimmune and/or inflammatory diseases

Methods of treatment using CCR8 antibodies

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

ANTI-TIRC7 ANTIGEN BINDING PROTEINS

ANTI IL-33 THERAPEUTIC AGENT FOR TREATING RENAL DISORDERS

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND IL-23

LTBP complex-specific inhibitors of TGFβ and uses thereof

scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidity and specificity

Polyomavirus neutralizing antibodies

ANTI-BCMA ANTIBODY CONJUGATES

METHODS FOR DETERMINING ANTIBODY AFFINITY AND BINDING KINETICS USING VLPS OR LIVE VIRUSES ATTACHED TO BIOSENSORS

Binding molecules for BCMA and CD3

Sequences of anti-ecto-5'-nucleotidase antibodies

Humanized complement 5A receptor 1 antibodies and methods of use thereof

ISOLATED ANTIGEN-BINDING PROTEIN AND APPLICATION THEREOF

Frizzled receptor antibodies and uses thereof

CLEC9A BINDING AGENTS

BMA031 antigen binding polypeptides

CD3 BINDING MOLECULES

CD47 antigen-binding molecules

Human anti-semaphorin 4D antibody

Humanized, mouse or chimeric anti-CD47 monoclonal antibodies

IL-5 antibody, antigen binding fragment thereof, and medical application therefor

FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF

AMYLOID-BETA ANTIBODIES

Anti-Coronavirus Antibodies and Methods of Use

DNMT3A KNOCKOUT CAR T CELLS FOR ADOPTIVE IMMUNOTHERAPY

ENGINEERED IMMUNOGLOBULINS WITH ALTERED FCRN BINDING

Anti-renalase antibodies for the treatment and prevention of diseases and disorders

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

Chimeric antigen receptor cells for treating solid tumor

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

ANTI-CLAUDIN 18.2 AND ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

METHODS AND COMPOSITIONS FOR INCREASING ENZYME ACTIVITY IN THE CNS

Anti-CXCR2 antibodies and uses thereof

Antibodies or antigen-binding fragments that bind to OX40

ANTIBODY BINDING SPECIFICALLY TO B7-H3 AND USE THEREOF

Antibodies that bind CD3 Epsilon

Anti-sortilin antibodies and methods of use thereof

RECOMBINANT ANTIBODIES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF

ENTPD2 ANTIBODIES, COMBINATION THERAPIES, AND METHODS OF USING THE ANTIBODIES AND COMBINATION THERAPIES

ANTI-TIGIT IMMUNOSUPPRESSANT AND APPLICATION THEREOF

ANTI-CCL17 ANTIBODIES

ANTI-BETACELLULIN ANTIBODIES, FRAGMENTS THEREOF, AND MULTI-SPECIFIC BINDING MOLECULES

THERAPEUTIC NEUTRALIZATION ANTIBODIES FOR THE TREATMENT OF PEANUT ALLERGY

Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof

RABBIT-DERIVED ANTIGEN BINDING PROTEIN NUCLEIC ACID LIBRARIES AND METHODS OF MAKING THE SAME

COMBINATION THERAPY WITH ENTPD2 AND CD73 ANTIBODIES

MODIFIED FC REGION

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

UPAR ANTIBODIES AND FUSION PROTEINS WITH THE SAME

ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

Chimeric antigen receptors targeting B-cell maturation antigen

NKp46 BINDING AGENTS

NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOF

ANTIBODY AND BISPECIFIC ANTIBODY TARGETING LAG-3 AND USE THEREOF

ANTIBODY CAPABLE OF BINDING TO THYMIC STROMAL LYMPHOPOIETIN AND USE THEREOF

Human antibodies to artemin and methods of use thereof

ANTI-ALPHA-SYNUCLEIN ANTIBODIES

Dual cytokine fusion proteins comprising IL-10

CD8-specific antibody constructs and compositions thereof

HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM

FIBROBLAST ACTIVATION PROTEIN BINDING AGENTS AND USE THEREOF

A METHOD FOR PREVENTING HUMAN VIRUS ASSOCIATED DISORDERS IN PATIENTS

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

Antibodies and polypeptides directed against CD127

Peptidomimetic-based antibody surrogate for HER2

HUMANIZED ANTIBODIES AGAINST PD-L1

ANTI-CD47/ANTI-PD-1 BISPECIFIC ANTIBODY, PREPARATION METHOD AND USE THEREOF

METHODS OF TREATING CANCER

ANTI-TIGIT ANTIBODIES

Complement C2 Binding Proteins and Uses Thereof

NOVEL ANTI-ZIKA VIRUS ANTIBODIES AND USES THEREOF

ANTI-IgE CONSTRUCT

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Methods for Predicting and Modulating Glycation of a Protein

EXPRESS HUMANIZATION OF ANTIBODIES

MONOCLONAL ANTIBODY WHICH TARGETS TFPI

COMPOSITIONS AND METHODS TARGETING THE NUCLEOTIDE FREE STATE OF RAS TO BLOCK ONCOGENIC SIGNALING AND TRANSFORMATION

SSEA-4 BINDING MEMBERS

ADAM9-Binding Molecules, and Methods of Use Thereof

Bispecific Antibody, Preparation Method Therefor and Application Thereof

Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy

Anti-CD40 antibodies and uses thereof

Methods for the treatment of thyroid eye disease

DOSING FOR TREATMENT WITH ANTI-TIGIT AND ANTI-PD-L1 ANTAGONIST ANTIBODIES

Anti-PD-1 antibodies and methods of treating cancer

NOVEL ANTI-CD4 ANTIBODIES

Activatable Multi-Specific Antigen Binding Protein Complexes

MATERIALS AND METHODS FOR MULTIDIRECTIONAL BIOTRANSPORTATION

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

ANTIGEN-BINDING MOLECULE FOR PROMOTING CLEARANCE FROM PLASMA OF ANTIGEN COMPRISING SUGAR CHAIN RECEPTOR-BINDING DOMAIN

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS THAT TARGET TACI

Anti-IL31 Antibodies for Veterinary Use

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

ANTI-CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY AND APPLICATION THEREOF

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE

ANTI-HER2 AFFIBODY AND SWITCHABLE CHIMERIC ANTIGEN RECEPTOR USING SAME AS SWITCH MOLECULE

Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof

Trispecific antibody targeting CD79b, CD20, and CD3

Antibodies targeting B-cell maturation antigen and methods of use

Multivalent FZD and WNT Binding Molecules and Uses Thereof

ANTI-PD-L1 SINGLE-DOMAIN ANTIBODY AND DERIVATIVES AND USE THEREOF

Anti-Siglec-5 antibodies and methods of use thereof

BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF

Anti P2X7 receptor antibodies and fragments thereof

Modified-IgG antibodies that bind transforming growth factor-BETA1 with high affinity, avidity and specificity

Anti-TDP-43 Binding Molecules and Uses Thereof

COMPOSITIONS AND METHODS RELATED TO HUMAN NEUTRALIZING ANTIBODIES TO HEPATITIS B

COMBINATION THERAPY FOR THE TREATMENT OF SOLID AND HEMATOLOGICAL CANCERS

METHODS FOR SELECTING PHOSPHATASE SELECTIVE AND NON-SELECTIVE PHOSPHATASE INHIBITORS

BIOMARKERS FOR DISEASE PROGRESSION IN SQUAMOUS CELL CARCINOMA

THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR TREATMENT OF SHOCK

VARIANT NUCLEIC ACID LIBRARIES FOR TIGIT

Heterodimeric antibodies that bind CD3 and GPC3

A SINGLE-DOMAIN ANTIBODY FOR TARGETING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA)

ANTI-CD38 ANTIBODY AND METHODS OF USE THEREOF

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies

Therapeutic binding molecules

EPHA2 antibodies

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

IL1RAP ANTIBODIES

Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same

Single Domain Antibodies to Programmed Cell Death (PD-1)

MATERIALS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

Antibody targeting CD22 and CD79B

ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF

COMPOSITIONS INCLUDING IGG FC MUTATIONS AND USES THEREOF

Anti-TIGIT antibodies

METHODS OF TREATING CANCER BY TARGETING ZSCAN4 ACTIVITY IN CANCER STEM CELLS

Antibody drug conjugates for ablating hematopoietic stem cells

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

MODIFIED FC-REGIONS TO ENHANCE FUNCTIONAL AFFINITY OF ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF

ANTI-B7-H3 ANTIBODY AND METHODS OF USE THEREOF

Anti-TMEFF1 antibodies and antibody drug conjugates

ANTI AQP3 MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO EXTRACELLULAR DOMAIN OF AQUAPORIN 3 (AQP3) AND USE THEREOF

ANTI-HUMAN P40 PROTEIN DOMAIN ANTIBODY AND USE THEREOF

Novel Molecules for Therapy and Diagnosis

Transgenic Non-Human Vertebrate for the Expression of Class-Switched, Fully Human, Antibodies

EX VIVO GAMMA DELTA T CELL POPULATIONS

CHEMICALLY CONTROLLED MONOCLONAL ANTIBODY TARGET ENGAGEMENT

Immunomodulatory antibodies and methods of use thereof

ADAMTS binding immunoglobulins

ANTI-CD40 ANTIBODIES AND USES THEREOF

Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR

CAR FOR USE IN THE TREATMENT OF HVG DISEASE

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

Anti-SIRPa antibodies and methods of use thereof

ANTI-CD19 ANTIBODIES AND USES THEREOF

Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents

Anti-PACAP antibodies and uses thereof

ANTIBODIES BINDING TSLP AND USES THEREOF

ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES THEREOF

FUSION PROTEIN TARGETING PD-L1 AND TGF-ß AND USE THEREOF

STERIC EPITOPE OF CEACAM1, AND ANTI-CEACAM1 ANTIBODY, OR FRAGMENT THEREOF, THAT SPECIFICALLY BINDS TO SAME

LILRB1-based chimeric antigen receptor

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Anti-podocalyxin antibodies and methods of using the same

MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF

CAR-T CELL COMPOSITIONS, METHODS OF USE THEREOF

Immunomodulating transgenic plants and related methods

Compositions and methods to regulate Renalase in the treatment of cancer

Anti-FAP antibodies and methods of use

Anti-SIRPa antibodies and their therapeutic applications

ANTI-TNFR2 ANTIBODIES AND USES THEREOF

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing)

TREM2 ANTIBODIES AND USES THEREOF

ANTIBODIES AND BLOCKING THE INTERACTION OF VISTA AND ITS BINDING PARTNER

ANTI-IL13 ANTIGEN BINDING PROTEINS

Antibodies directed against GDF-15

TETRANECTIN-TARGETING MONOCLONAL ANTIBODIES TO FIGHT AGAINST LETHAL SEPSIS AND OTHER PATHOLOGIES

Dual cytokine fusion proteins comprising IL-10

METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY

ANTIBODIES TO CANDIDA AND USES THEREOF

ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF

ANTIBODIES AGAINST PD-1 AND METHODS OF USE THEREOF

Bispecific Epitope Binding Protein Comprising Anti-4-1BB Antibody and a PD-1 Protein or Fragments Thereof and Use Thereof

Covalent Diabodies and Uses Thereof

Anti-myostatin antibodies and methods of use

COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2 ANTIBODY

ANTIBODIES RECOGNIZING TAU

Single domain antibodies binding to tetanus neurotoxin

Antibody compositions for disrupting biofilms

Anti-CHIKV antibodies and uses thereof

ANTIBODIES

RELAXIN ANALOGS AND METHODS OF USING THE SAME

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

ANTI-CD47/ANTI-TIGIT BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Human Anti-SOD1 Antibodies

NOVEL BSSL ANTIBODIES

ANTI-FUCOSYL-GM1 ANTIBODIES